MAPT and Alzheimer disease: CKD‐504 effectively modified acetylation both in brain organoids formed from AD patient‐derived induced pluripotent stem cells (iPSCs) and ADLPAPT (Alzheimer's disease‐like pathologyAPP & Tau) mice exhibiting both Aβ and tau pathologies (Kim et al., 2018).